Clinical Trial Update: Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme [NA]

View source ↗

Summary

A Phase II trial evaluating neoadjuvant temozolomide before concurrent temozolomide with accelerated hypofractionated external beam radiotherapy, followed by ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Glioblastoma Mutliforme | NA | Status: COMPLETED